Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oncophage vs Observation in Adjuvant Renal Cell Carcinoma
NCT00033904Phase 3Completed
- Sponsor
- Agenus Inc.
- Start
- Jun 2000
- Primary completion
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 11
01
Overview
A Phase 3 trial of vitespen in renal cell carcinoma (RCC), sponsored by Agenus Inc.. Started Jun 2000; status: completed.
02
Drugs
vitespen
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00033904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033904.